IGF1 and breast cancer: In addition to these observational studies, investigations of genetic determinants of breast cancer risk in BRCA1 mutation carriers have identified associations with genetic variants in the IGF-IR [54] and IGF-II [55], indicating that the IGF-pathway is causally related to breast cancer development in women with BRCA1 mutations.